Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia-Reference-Cited by-同舟云学术

Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemia

Published:2006-04-10 Issue:11 Volume:37 Page:1003-1008
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Elliott M A,Tefferi A,Hogan W J,Letendre L,Gastineau D A,Ansell S M,Dispenzieri A,Gertz M A,Hayman S R,Inwards D J,Lacy M Q,Micallef I N,Porrata L F,Litzow M R

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705369.pdf

Reference13 articles.

1. Vardiman JW, Harris NL, Brunning RD . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302.

2. Onida F, Kantarjian HM, Smith TL, Ball G, Keating MJ, Estey EH et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 2002; 99: 840–849.

3. Germing U, Kundgen A, Gattermann N . Risk assessment in chronic myelomonocytic leukemia (CMML). Leukemia Lymphoma 2004; 45: 1311–1318.

4. Wattel E, Guerci A, Hecquet B, Economopoulos T, Copplestone A, Mahe B et al. A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Francais des Myelodysplasies and European CMML Group. Blood 1996; 88: 2480–2487.

5. Kroger N, Zabelina T, Guardiola P, Runde V, Sierra J, Van Biezen A et al. Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2002; 118: 67–73.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management;American Journal of Hematology;2024-03-07

2. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study;Bone Marrow Transplantation;2024-02-08

3. EASIX and CPSS Cytogenetics score-based composite risk model for patients with CMML undergoing allogeneic transplant;Bone Marrow Transplantation;2024-01-13

4. Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms;Cancers;2023-07-27

5. High EASIX score is an independent predictor of non-relapse mortality in patients with CMML undergoing allogeneic stem cell transplant;Bone Marrow Transplantation;2022-09-21